Success Metrics

Clinical Success Rate
66.7%

Based on 2 completed trials

Completion Rate
67%(2/3)
Active Trials
4(40%)
Results Posted
0%(0 trials)
Terminated
1(10%)

Phase Distribution

Ph not_applicable
2
20%
Ph phase_4
3
30%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Phase 4Post-market surveillance
3(60.0%)
N/ANon-phased studies
2(40.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(2)
Terminated(1)
Other(3)

Detailed Status

unknown3
Active, not recruiting2
Recruiting2
Completed2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (60.0%)
N/A2 (40.0%)

Trials by Status

terminated110%
active_not_recruiting220%
recruiting220%
completed220%
unknown330%

Recent Activity

4 active trials
Showing 5 of 10
recruiting

REGistry of Long-term AnTithrombotic TherApy-1

NCT04347200
terminatedphase_4

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

NCT03062319
recruitingphase_4

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

NCT05995600
active_not_recruitingphase_4

Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

NCT05122780
unknown

Monitoring Antiplatelet Drugs in Cardiac Arrest Patients

NCT05730114
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04347200

REGistry of Long-term AnTithrombotic TherApy-1

Recruiting
NCT03062319Phase 4

Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

Terminated
NCT05995600Phase 4

Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKE

Recruiting
NCT05122780Phase 4

Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).

Active Not Recruiting
NCT05730114

Monitoring Antiplatelet Drugs in Cardiac Arrest Patients

Unknown
NCT05053828

Type 2 Diabetes With Antiplatelet Drugs

Completed
NCT05475080

Carotid Web and Stroke Registry.

Unknown
NCT02843633Not Applicable

LEADERS FREE II: BioFreedom™ Pivotal Study

Active Not Recruiting
NCT04548401

Effect of Antiplatelet Therapy on Cognition After Aneurysmal Subarachnoid Hemorrhage

Unknown
NCT02800174Not Applicable

Smart Nitinol Stent System for the Treatment of Severe Atherosclerotic Carotid Stenosis

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10